✦ LIBER ✦

Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia

✍ Scribed by Zetterquist, H; Mattsson, J; Uzunel, M; Näsman-Björk, I; Svenberg, P; Tammik, L; Bayat, G; Winiarski, J; Ringdén, O

Book ID: 110012515
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 164 KB
Volume: 25
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1702337

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Minimal residual disease levels in bone

Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL

✍ van der Velden, V H J; Jacobs, D C H; Wijkhuijs, A J M; Comans-Bitter, W M; Will 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB

Targeted therapy with the T-cell - Engag

Targeted therapy with the T-cell - Engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival

✍ Topp, Max S. (author);Kufer, Peter (author);Gökbuget, Nicola (author);Goebeler, 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 135 KB

Targeted therapy with the T-cell - Engag

✍ Topp, Max S. (author);Kufer, Peter (author);Gökbuget, Nicola (author);Goebeler, 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 135 KB

Eradication of Minimal Residual Disease

Eradication of Minimal Residual Disease with Alemtuzumab in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients: The Need for a Standard Method of Detection and the Potential Impact of Bone Marrow Clearance on Disease Outcome

✍ Montillo, Marco; Schinkoethe, Timo; Elter, Thomas 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 133 KB

The risk of residual molecular and cytog

The risk of residual molecular and cytogenetic disease in patients with philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone marrow: A. Elmaagacli, D. Beelen, B. Opalka, et al. Blood 94:384–389, 1999

✍ Christopher D. Hillyer 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB